GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncopeptides AB (LTS:0RN4) » Definitions » 6-Month Price Index

Oncopeptides AB (LTS:0RN4) 6-Month Price Index : 0.94 (As of Apr. 29, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Oncopeptides AB 6-Month Price Index?

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2025-04-29), Oncopeptides AB's 6-Month Price Index is 0.94.

Competitive Comparison of Oncopeptides AB's 6-Month Price Index

For the Biotechnology subindustry, Oncopeptides AB's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncopeptides AB  (LTS:0RN4) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncopeptides AB  (LTS:0RN4) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

Oncopeptides AB 6-Month Price Index Related Terms

Thank you for viewing the detailed overview of Oncopeptides AB's 6-Month Price Index provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncopeptides AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncopeptides AB (LTS:0RN4) » Definitions » 6-Month Price Index
Comparable Companies
OSTO:CANTA OSTO:INIT OSTO:IRLAB A OSTO:IVACC XSAT:CESSA OSTO:LIPUM OSTO:ISOFOL OSTO:ACE OSTO:XBRANE OSTO:XINT VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
ONCO:Sweden OND:Germany
Address
Vastra Tradgardsgatan 15, Stockholm, SWE, SE-111 53
Website
https://www.oncopeptides.com
Oncopeptides AB is a biotech company focused on the research, development, and commercialization of therapies for difficult-to-treat hematological diseases. The company uses its proprietary Peptide Drug Conjugate (PDC) to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells. It has focused on the development of the product candidate Melflufen (Pepaxti), a peptide-conjugated alkylator, belonging to a new class of drugs called Peptidase Enhanced Compounds. Melflufen is intended as an effective treatment for hematological cancers and in particular multiple myeloma.

Oncopeptides AB Headlines

No Headlines